These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2870686)
1. Central and peripheral effects of S 3341 [(N-dicyclopropylmethyl)-amino-2-oxazoline] in animal models. van Zwieten PA; Thoolen MJ; Jonkman FA; Wilffert B; de Jonge A; Timmermans PB Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):130-49. PubMed ID: 2870686 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. Laubie M; Poignant JC; Scuvée-Moreau J; Dabire H; Dresse A; Schmitt H J Pharmacol; 1985; 16(3):259-78. PubMed ID: 2866274 [TBL] [Abstract][Full Text] [Related]
3. Hypotensive and alpha-adrenergic activities of 2-(2,3,6-trichlorophenylimino) and 2-(2,3-dichloro-6-methylphenylimino) imidazolidine, two potent derivatives of clonidine. de Jonge A; Timmermans PB; van Zwieten PA Br J Pharmacol; 1983 Mar; 78(3):479-87. PubMed ID: 6132639 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive activity and interaction with alpha-adrenoceptors of tibalosine ([1-(2, 3-dihydro-5-benzo-(b)-thienyl)-2-(4-phenyl-butylamino)-1-propanol], CP 804 S) in rat and cat preparations. Qian JQ; Mathy MJ; Thoolen MJ; Timmermans PB; van Zwieten PA Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):264-81. PubMed ID: 6141776 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats. Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153 [TBL] [Abstract][Full Text] [Related]
6. Sgd 101/75: cardiovascular effects in various animal preparations; interactions with vascular postjunctional alpha 1- and alpha 2-adrenoceptors. Mathy MJ; Thoolen MJ; Timmermans PB; van Zwieten PA Br J Pharmacol; 1984 Feb; 81(2):255-62. PubMed ID: 6142740 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects and interaction with adrenoceptors of urapidil. van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641 [TBL] [Abstract][Full Text] [Related]
8. Effects of urapidil on blood pressure and adrenoceptors in various animal models. van Zwieten PA; Mathy MJ; Thoolent MJ; Wilffert B; de Jonge A; Timmermans PB J Hypertens Suppl; 1984 Dec; 2(3):S539-41. PubMed ID: 6599713 [TBL] [Abstract][Full Text] [Related]
9. Effects of continuous infusions (10 days) and cessation of infusions of clonidine and rilmenidine (S 3341) on cardiovascular and behavioral parameters of spontaneously hypertensive rats. Jarrott B; Lewis SJ; Doyle AE; Louis WJ Am J Cardiol; 1988 Feb; 61(7):39D-44D. PubMed ID: 2894156 [TBL] [Abstract][Full Text] [Related]
10. Selective stimulation of vascular postjunctional alpha-adrenoreceptors by (-)-amidephrine in rats and cats. Mathy MJ; Doods HN; Thoolen MJ; Wilffert B; de Jonge A; Timmermans PB; Van Zwieten PA J Auton Pharmacol; 1983 Dec; 3(4):249-55. PubMed ID: 6141169 [TBL] [Abstract][Full Text] [Related]
11. Interference of enantiomers of lofexidine with alpha-adrenoceptors. Wilffert B; Mathy MJ; Batink HD; de Jonge A; Thoolen MJ; Prop G; Graf E; Timmermans PB; van Zwieten PA Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):18-32. PubMed ID: 2988468 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular actions of medetomidine and their reversal by atipamezole. Savola JM Acta Vet Scand Suppl; 1989; 85():39-47. PubMed ID: 2571276 [TBL] [Abstract][Full Text] [Related]
13. Evidence for central alpha 2-adrenoceptor-mediated hypertension in freely moving, normotensive rats. Kawasaki H; Takasaki K Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):217-33. PubMed ID: 2892472 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine. Van Zwieten PA Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160 [TBL] [Abstract][Full Text] [Related]
15. Prejunctional alpha 2-adrenergic properties of S-3341 (dicyclopropylmethyl)amino-2-delta-2-oxazoline: a comparison with clonidine. Bourreau JP; Tricoche R Can J Physiol Pharmacol; 1987 Dec; 65(12):2496-9. PubMed ID: 2896539 [TBL] [Abstract][Full Text] [Related]
16. Further studies on central actions of nitroglycerin and lack of evidence for nitroglycerin interacting on [3H]clonidine binding sites in cortex membranes. Ma S; Long JP; Bhatnagar RK J Pharmacol Exp Ther; 1992 Jun; 261(3):1187-94. PubMed ID: 1318374 [TBL] [Abstract][Full Text] [Related]
17. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Armah BI; Hofferber E; Stenzel W Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383 [TBL] [Abstract][Full Text] [Related]
18. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats. Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583 [TBL] [Abstract][Full Text] [Related]
19. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Raasch W; Schäfer U; Qadri F; Dominiak P Br J Pharmacol; 2002 Feb; 135(3):663-72. PubMed ID: 11834614 [TBL] [Abstract][Full Text] [Related]
20. MR-14134, a new benzothiazepine with central hypotensive action. Prieto P; Carrón R; Montero MJ; Morán A; Román LS Pharmacology; 1995 Aug; 51(2):84-95. PubMed ID: 8584576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]